The Rocky Mountain Blood and Marrow Transplant Program (RMBMTP) is advancing care for patients with blood and marrow disorders through compassionate treatment, education and research.

We offer the Rocky Mountain Region's largest full-service stem cell and bone marrow transplant program. We perform autologous transplants and allogeneic transplants as well as a full range of cellular therapies, including DLI's and photopheresis for Chronic Graft Versus Host Disease (cGVHD). We offer treatments for hematological diseases and disorders with classifications of Aplastic Anemia, Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Amyloidosis, Chronic Lymphocitic Leukemia (CLL), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL) and Testicular Cancer.

The Program is the only adult National Marrow Donor Program (NMDP) donor, collection and transplant facility in Colorado, as well as Colorado’s only adult allogeneic FACT accredited program performing both related donor and unrelated donor transplants. RMBMTP recently expanded the unrelated donor program to include cord blood transplants.

RMBMTP’s research efforts are driven from a desire to broaden the scope of eligible stem cell transplant recipients. Through the use of non-myeloablative or reduced intensity allogeneic transplants and cord blood transplants we are able to broaden both the age and ethnicity of our potential patient population.

Our transplant team includes a program psychologist, social worker, dietitian, nurse practitioners, medical assistants, financial and transplant nurse coordinators, and oncology certified registered nurses. Our Long Term Follow Up Program manages the possible complications of our allogeneic patient's Graft Versus Host Disease (GVHD), we not only follow the patient but are also a resource for our referring physicians whose patient's have returned to their care.

The program's volume has grown steadily over the past 16 years. In December of 2005 we performed our 1000th transplant. Current annual volumes exceed 150 stem cell and bone marrow transplants. While our facilities are in the heart of Denver, Colorado our patients come from Nebraska, Wyoming, Kansas, Utah, Montana, Arizona and Western Colorado.





Related Keywords: Allogeneic, Chronic Myelogenous Leukemia, Severe Aplastic Anemia (SAA), Myelodysplastic Syndrome (MDS), Peripheral Blood Stem Cell (PBSC), HLA-Matched Sibling Donor, HLA-Matched Family Member, HLA-Matched, Graft-Versus-Host Disease (GVHD), Donor Stem Cells, Donor Lymphocyte Infusion (DLI), Chronic GVHD, Aplastic Anemia, Leukemia
Related Resources: National Marrow Donor Program, The Myelodysplastic Syndromes Foundation, Multiple Myeloma Research Foundation, Lymphoma Research Foundation, Leukemia Research Foundation, Aplastic Anemia and MDS International Foundation, Amyloidosis Support Network, National Cancer Institute, The Leukemia and Lymphoma Society
Related Glossary Terms: Ablative Transplants
 
UPCOMING EVENTS
 
Young Adult Support Group
Leukemia and Lymphoma Society Family Support Groups
Family Member and Caregiver Support Group
 
RECENT NEWS
 
Cyclacel reports survival data from phase 2 sapacitabine study in elderly patients with acute myeloid leukemia
Second gene linked to familial testicular cancer
ASCO Presentation Highlights Memgen's ISF35 Anti-Cancer Activity in Chronic Lymphocytic Leukemia
Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia
Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors